Question 1

What does Alexion Pharmaceuticals do?

Accepted Answer

Alexion Pharmaceuticals is a biopharmaceutical company that engages in the development and commercialization of mid-to-late-stage therapies.

Question 2

In what sectors does Alexion Pharmaceuticals operate?

Accepted Answer

Alexion Pharmaceuticals operates in Biotechnology, Health Care, Medical, Therapeutics.

Question 3

How many companies has Alexion Pharmaceuticals acquired?

Accepted Answer

Alexion Pharmaceuticals has made 8 acquisitions between 2011-2022, with a total disclosed deal value of $11.2B.

Question 4

How many acquisitions does Alexion Pharmaceuticals make in a year?

Accepted Answer

Over the last 5 years, Alexion Pharmaceuticals has made about 1 acquisitions per year.

Question 5

What companies are owned by Alexion Pharmaceuticals?

Accepted Answer

Companies acquired by Alexion Pharmaceuticals include LogicBio Therapeutics, Portola Pharmaceuticals, Achillion Pharmaceuticals, Syntimmune, Wilson Therapeutics, Synageva BioPharma, Enobia Pharma, Taligen Therapeutics.

Question 6

What are Alexion Pharmaceuticals's major acquisitions?

Accepted Answer

Alexion Pharmaceuticals's largest acquisitions include Synageva BioPharma ($8.4B, 2015), Portola Pharmaceuticals ($1.4B, 2020), Syntimmune ($1.2B, 2018), Taligen Therapeutics ($111.0M, 2011).

Question 7

What is Alexion Pharmaceuticals's largest acquisition?

Accepted Answer

Alexion Pharmaceuticals's largest disclosed acquisition is Synageva BioPharma for $8.4B (2015).

Question 8

What was Alexion Pharmaceuticals's first acquisition?

Accepted Answer

Alexion Pharmaceuticals's first recorded acquisition was Taligen Therapeutics in 2011 for $111.0M.

Question 9

What was Alexion Pharmaceuticals's most recent acquisition?

Accepted Answer

Alexion Pharmaceuticals's most recent acquisition is LogicBio Therapeutics, announced October 2022 for $70.0M.

Question 10

What is the average deal size for Alexion Pharmaceuticals acquisitions?

Accepted Answer

The average disclosed deal size for Alexion Pharmaceuticals acquisitions is $2.2B.

Question 11

What is the median deal size for Alexion Pharmaceuticals acquisitions?

Accepted Answer

The median disclosed deal size for Alexion Pharmaceuticals acquisitions is $1.2B. The median is often lower than the average because a few very large deals pull the average up.

Question 12

How much has Alexion Pharmaceuticals spent on acquisitions?

Accepted Answer

Alexion Pharmaceuticals has spent at least $11.2B across its disclosed acquisitions (of 8 total deals; some prices are undisclosed).

Question 13

Which sector has Alexion Pharmaceuticals spent the most on?

Accepted Answer

Alexion Pharmaceuticals has committed the most disclosed capital to Biotechnology companies — about $11.2B across its deals in that sector.

Question 14

What sectors does Alexion Pharmaceuticals usually acquire in?

Accepted Answer

Alexion Pharmaceuticals most frequently acquires companies in Biotechnology, Health Care, Therapeutics.

Question 15

In which sector has Alexion Pharmaceuticals made the most acquisitions?

Accepted Answer

Alexion Pharmaceuticals has made the most acquisitions in the Biotechnology sector.

Question 16

In which year did Alexion Pharmaceuticals make the most acquisitions?

Accepted Answer

Alexion Pharmaceuticals made the most acquisitions in 2018, with 2 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Alexion Pharmaceuticals

Company Details

Funding & Financials

IPO & Stock

Web Traffic

Technology & IP

Investor Activity

Company Info

Signals & Scores

Investments by Alexion Pharmaceuticals

Acquisitions by Alexion Pharmaceuticals

Key People at Alexion Pharmaceuticals

Explore 200,000+ acquisitions — free

Recent News related to Alexion Pharmaceuticals

FAQs about Alexion Pharmaceuticals

People who checked this page also checked these